Lv31
290 积分 2022-12-04 加入
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
3小时前
已完结
Genetic subtypes of B-cell acute lymphoblastic leukemia in adults
23天前
已完结
Healing the schism between public health and medicine, promoting the integration of prevention and treatment
3个月前
已完结
Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks
3个月前
已完结
Targeting metabolic dysfunction of CD8 T cells and natural killer cells in cancer
3个月前
已完结
CD38 x ICAM-1 Bispecific Antibody Is a Novel Approach for Treating Multiple Myeloma and Lymphoma
3个月前
已完结
Targeted Delivery of c(RGDfk)‐Modified Liposomes to Bone Marrow Through In Vivo Hitchhiking Neutrophils for Multiple Myeloma Therapy
4个月前
已完结
A modern view of LGL leukemia
4个月前
已关闭
Antibody-targeted T cells and natural killer cells for cancer immunotherapy
6个月前
已完结
Simvastatin Preferentially Targets FLT3/ITD Acute Myeloid Leukemia by Inhibiting MEK/ERK and p38-MAPK Signaling Pathways
6个月前
已完结
皖公网安备34019202002308
